Mass Tort brief
UK Class Actions Gain Momentum as Tribunals Clear Major Claims
From a landmark £4.5B housebuilder claim to Apple's iCloud battle, litigation finance and consumer advocates are driving a massive expansion in collective litigation.
Mass Tort
By letting juries evaluate disputed pregnancy safety science, US courts have revived massive litigation — keeping major pharmaceutical companies exposed to multi-billion-dollar liabilities.
BackgroundParacetamol is the most widely recommended pain and fever reliever for pregnant women across both the US and the UK. Class action litigation alleging developmental injuries has sparked fierce debate among medical professionals over long-standing drug safety guidelines.
- The US Second Circuit ruled the trial judge went too far as a gatekeeper by excluding expert testimonies, leaving scientific disputes for a jury to decide.
- Concurrently, a rapid review published in The BMJ concluded there is no clear causal link between prenatal use and autism, bolstering the pharmaceutical industry's defense.
- UK drug safety regulators recently reassured the public that paracetamol remains safe during pregnancy, limiting immediate litigation risks for manufacturers operating in British markets.
Mass Tort
Litigators are leveraging regulatory settlements to mount massive consumer class actions — exposing Britain's top housebuilders to multi-billion-pound payouts.
BackgroundThe Competition Appeal Tribunal hears antitrust class actions on behalf of affected consumer groups under opt-out rules that automatically include all eligible class members. Previously, claimants had to actively sign up for lawsuits, which severely limited the financial scale of consumer compensation cases.
- The lawsuit represents roughly 700,000 consumers who purchased new-build homes in Great Britain since October 2015, establishing the largest property-sector class action in UK history.
- Claimants seek compensation between £2.2 billion and £4.5 billion, which could yield payouts of up to £6,200 per individual homeowner if the tribunal rules in their favour.
- Litigation financier Burford Capital is backing the legal action with up to £29 million, demonstrating growing funder confidence in high-value UK consumer antitrust claims.
- The case builds on a previous Competition and Markets Authority probe that settled without formal findings, showing how litigators are turning regulatory investigations into private damages claims.
Mass Tort
UK tribunals are increasingly certifying massive opt-out class actions — forcing tech giants to defend their closed software ecosystems in court.
BackgroundTech platforms frequently face regulatory scrutiny for tying proprietary hardware to their cloud storage services. Litigators argue that restricting consumer choices allows these dominant firms to lock in users and charge inflated subscription fees.
- The consumer group Which? alleges Apple systematically abused its dominant position to trap iOS users in iCloud, forcing them to pay premium prices for expanded storage.
- The tribunal rejected Apple's attempts to block the claim and scheduled a full nine-week trial for October 2028, ensuring years of legal uncertainty for the firm.
- Litigation Capital Management is funding the suit, highlighting how third-party funders are increasingly willing to bankroll expensive, high-risk battles against Big Tech companies.
Mass Tort
London tribunals are enforcing strict transparency rules on litigation finance — warning class action firms that hiding funding problems carries severe financial penalties.
BackgroundClass action law firms rely heavily on third-party litigation funding to cover the high costs of complex commercial trials. English courts require complete transparency regarding financial backers to prevent conflicts of interest and ensure defendants can recover costs.
- The tribunal found the firm hid the collapse of an £18 million funding agreement with North Wall Capital, misleading both the court and its opponents.
- Judges summarily assessed costs at £608,000 and ordered an interim payment of £850,000 to defendants, imposing an immediate cash penalty on the law firm.
- Pogust Goodhead warned that the ruling highlights an increasingly hostile litigation funding environment in London, where courts are demanding greater disclosure from financial backers.
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.